Intracellular clearance of Coxsakievirus B3 infection by short interfering RNA and its mechanism study / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology
;
(6): 260-262, 2008.
Artigo
em Chinês
| WPRIM
| ID: wpr-254088
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the possibility of short interfering RNA (siRNA) inhibiting Coxsackievirus B3 (CVB3) infection in vitro, and discover the mechanism initially.</p><p><b>METHODS</b>We obtained proper effective dosage of siRNA by observing cytopathic effect (CPE). Estimate its antiviral activities and its pathway of siRNA by Western Blot assay and RT-PCR.</p><p><b>RESULTS</b>Results showed that siRNA-3753 can be effectively transfected into HeLa cells, we can achieve a high transfection efficiency up to 98.77% and its effect can last for 48 h stably in cells. 0.6 micromol/L siRNA-3753 got a high inhibiting effect of virus and didn't show any toxicity to cells. So we consider this concentration as the experimental concentration. siRNA-3753 can debase virus reproduction. The antiviral effect is sequence-specific and is not attributable to either interferon or the interferon response effectors protein kinase R (PKR).</p><p><b>CONCLUSION</b>The data confirmed that siRNA can effectively inhibit CVB3 infection in vitro, its antivirus effect was gained from specific debase of virus genome.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Terapêutica
/
Virologia
/
RNA Viral
/
Células HeLa
/
Enterovirus Humano B
/
Infecções por Coxsackievirus
/
RNA Interferente Pequeno
/
Interferência de RNA
/
Usos Terapêuticos
/
Genética
Limite:
Humanos
Idioma:
Chinês
Revista:
Chinese Journal of Experimental and Clinical Virology
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS